Valley fever is widespread to dry and hot areas such as California’s San Joaquin Valley and the southwestern US, but a new research forecasts climate change will lead to increase the range of fungal infections more than 2 times in size this century, reaching earlier untouched regions all over the western US.
In a new research posted in GeoHealth journal, researchers at the University of California claim that in a high-alerting scenario, the list of impacted states will jump to 17 from 12 and the number of people valley fever cases will increase by 50% by the end of 2100. The states planned to host recently widespread counties, which are Nebraska, Montana, South Dakota, North Dakota, and Wyoming, and the disease is anticipated to become more common in Idaho, Colorado, and Oklahoma, as per the research.
“The valley fever range is going to elevate considerably,” claimed Morgan Gorris, lead author of the new research. “We made predictions out to the end of the this century, and our model forecasts that valley fever will reach all over the Great Plains and farther north all over the western US, particularly in the Rocky Mountains’ rain shadow, and by that time, much of the western US will be considered prevalent.”
On a related note, in the middle of the deteriorating Ebola epidemic in the Congo, now threatening to spread into Rwanda, a new research recommends that a current, FDA-accepted drug dubbed as nitazoxanide might possibly assist control this highly contagious, deadly infection. In meticulous tests in human cells, headed by Boston Children’s Hospital, the drug considerably inhibited Ebola replication and increased immune reactions to Ebola.
The research, posted in the iScience journal, also displayed how the drug operates: It improves the ability of immune system to detect Ebola, usually impeded by the virus.